Los puntos clave no están disponibles para este artículo en este momento.
EO IBD is rising, warranting physicians' alertness for IBD in elderly patients. The long-term outcome was not different from AO disease, despite a less frequent use of immunomodulators and biologicals.
Jeuring et al. (Wed,) studied this question.